Sunday, October 21, 2018

Zenia Saridaki-Zoras

MD, PhD Medical Oncologist, Scientific Director of the Oncology Department “Asklepios”, Member of the Board of Directors of the Hellenic Society of Medical Oncology

Zenia Saridaki-Zoras
Zenia Saridaki-Zoras

Zenia Saridaki – Zoras is a Medical Oncologist and the Scientific Director of the Oncology Department “Asklepios”, situated in Heraklion, Crete, Greece.

With a Medical Degree and a PhD from the Medical School of the University of Crete she has a clinical and a laboratory research activity (mainly in colon cancer and breast cancer) both in Greece and abroad (she has worked as an academic visitor in the Genomic Instability Group of the Roy Castle International Center for Lung Cancer Research, Liverpool, with Dr Lakis Lilolgou, in the Medical Oncology Unit of the Churchill and John Radcliffe Hospitals and in the Department of Clinical Pharmacology of the Radcliffe Infirmary with Professor David J Kerr, as well as a postdoctoral scientific researcher in the Center for Human Genetics O&N1, Katholieke Universiteit, KU Leuven and in the Department of Digestive Oncology, University Hospital Gasthuisberg, Leuven, Belgium with Professor Sabine Tejpar).

She has 46 publications in scientific journals and she is a contributing author in 3 scientific books. She has been an elected Member of the Board of Directors of the Hellenic Society of Medical Oncology since 2013, and she is now in her 3rd term.

Keynote Speakers

A. John Iafrate Dr. Iafrate is a Professor of Pathology at Harvard Medical School and is Director of the Center for Integrated Diagnostics (CID), a clinical laboratory for molecular diagnostics and newly appointed Vice Chair of Academic Affairs at the Massachusetts General Hospital (MGH).
Stephen Palmer Stephen Palmer is a Professor and Deputy Director of TEEHTA. He has worked in economic evaluation for over 15 years in areas including pharmaceuticals, cardiology, cancer, mental health, diagnostic and screening programmes and policy. He has extensive experience of health economic evaluation, regulatory and reimbursement processes.
Luca Sangiorgi He is Head of Department of Medical Genetics and Coordinator of Rare Disease Centre at Rizzoli Orthopaedic Institute, Bologna, and Contract professor of Clinical Genetics of Bologna University.
  • ORGANIZED BY
  • UNDER THE AUSPICES OF
  • SPONSORS
  • SUPPORTERS
MSD
  • MEDIA PARTNER
  • MEDIA SPONSORS
  • INTERPRETATION SPONSOR
  • CONFERENCE EXPERIENCE SPONSOR

© 2018 Boussias Communications, all rights reserved. info@boussias.com, T:210 6617777, F:210 6617778

Designed by Boussias
New Media Team